Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 9, Number 5, September 2011

Articles

Open Access “European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
pp. 531-532(2)
Authors: P. Mikhailidis, Dimitri; Elisaf, Moses; Rizzo, Manfredi; Berneis, Kaspar; Griffin, Bruce; Zambon, Alberto; Athyros, Vasilios; de Graaf, Jacqueline; Marz, Winfried; G. Parhofer, Klaus; Battista Rini, Giovam; A. Spinas, Giatgen; H. Tomkin, Gerald; D. Tselepis, Alexandros; S. Wierzbicki, Anthony; Winkler, Karl; Florentin, Matilda; Liberopoulos, Evangelos

Favourites:
ADD

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
pp. 533-571(39)
Authors: P. Mikhailidis, Dimitri; Elisaf, Moses; Rizzo, Manfredi; Berneis, Kaspar; Griffin, Bruce; Zambon, Alberto; Athyros, Vasilios; de Graaf, Jacqueline; Marz, Winfried; G. Parhofer, Klaus; Battista Rini, Giovam; A. Spinas, Giatgen; H. Tomkin, Gerald; D. Tselepis, Alexandros; S. Wierzbicki, Anthony; Winkler, Karl; Florentin, Matilda; Liberopoulos, Evangelos

Favourites:
ADD

Medical Therapy of Aortic Aneurysms: A Pathophysiology-Based Approach
pp. 572-584(13)
Authors: Muscogiuri, Giovanna; Pio Sorice, Gian; Tripathy, Devjit; O. Chavez, Alberto; Davalli, Alberto; A. Lange, Richard; Folli, Franco

Favourites:
ADD

Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
pp. 594-605(12)
Authors: Waanders, Femke; V. de Vries, Laura; van Goor, Harry; Hillebrands, Jan-Luuk; D. Laverman, Gozewijn; J. L. Bakker, Stephan; Navis, Gerjan

Favourites:
ADD

Pathophysiology of Thrombosis and Potential Targeted Therapies in Antiphospholipid Syndrome
pp. 606-618(13)
Authors: Amengual, Olga; Atsumi, Tatsuya; Koike, Takao

Favourites:
ADD

Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
pp. 619-628(10)
Authors: Bautista-Hernandez, Victor; Sanchez-Andres, Antonio; Portela, Francisco; Fynn-Thompson, Francis

Favourites:
ADD

Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
pp. 629-646(18)
Authors: Semeraro, Francesco; Morescalchi, Francesco; Parmeggiani, Francesco; Arcidiacono, Barbara; Costagliola, Ciro

Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more